Also known as copper peptide-1 or copper tripeptide-1
Ozempic is the injectable peptide GLP-1 medicine with the most FDA-approved uses in type 2 diabetes, with indications to improve blood sugar along with diet and exercise, to reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults who also have known heart disease, and to reduce the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease.1 Ozempic injection and Ozempic tablets are not approved for use in children.
Beyond the metabolic pathways highlighted previously, the dataset contained a variety of proteins of demonstrated importance to cardiac function and disease
Other GLP-1 injectable drugs include Mounjaro, Trulicity, and Saxenda
If you are experiencing signs of vitamin B12 deficiency, its important to consult with your GP